1. Home
  2. EVAX vs RDHL Comparison

EVAX vs RDHL Comparison

Compare EVAX & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • RDHL
  • Stock Information
  • Founded
  • EVAX 2008
  • RDHL 2009
  • Country
  • EVAX Denmark
  • RDHL Israel
  • Employees
  • EVAX N/A
  • RDHL N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • RDHL Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVAX Health Care
  • RDHL Health Care
  • Exchange
  • EVAX Nasdaq
  • RDHL Nasdaq
  • Market Cap
  • EVAX 8.7M
  • RDHL 8.2M
  • IPO Year
  • EVAX 2021
  • RDHL N/A
  • Fundamental
  • Price
  • EVAX $2.78
  • RDHL $5.57
  • Analyst Decision
  • EVAX Strong Buy
  • RDHL
  • Analyst Count
  • EVAX 3
  • RDHL 0
  • Target Price
  • EVAX $33.33
  • RDHL N/A
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • RDHL 10.6K
  • Earning Date
  • EVAX 03-26-2025
  • RDHL 04-07-2025
  • Dividend Yield
  • EVAX N/A
  • RDHL N/A
  • EPS Growth
  • EVAX N/A
  • RDHL N/A
  • EPS
  • EVAX N/A
  • RDHL N/A
  • Revenue
  • EVAX $3,295,000.00
  • RDHL $3,707,000.00
  • Revenue This Year
  • EVAX $9,039.73
  • RDHL $224.90
  • Revenue Next Year
  • EVAX $1.47
  • RDHL $82.69
  • P/E Ratio
  • EVAX N/A
  • RDHL N/A
  • Revenue Growth
  • EVAX N/A
  • RDHL N/A
  • 52 Week Low
  • EVAX $2.22
  • RDHL $5.41
  • 52 Week High
  • EVAX $22.50
  • RDHL $20.28
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 41.99
  • RDHL 35.64
  • Support Level
  • EVAX $2.30
  • RDHL $5.50
  • Resistance Level
  • EVAX $4.05
  • RDHL $6.26
  • Average True Range (ATR)
  • EVAX 1.10
  • RDHL 0.32
  • MACD
  • EVAX 0.02
  • RDHL -0.02
  • Stochastic Oscillator
  • EVAX 7.39
  • RDHL 3.08

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

Share on Social Networks: